Friday, April 29, 2011

Amgen to Present at the Deutsche Bank 36th Annual Healthcare Conference

THOUSAND OAKS, Calif., April 28, 2011 /PRNewswire via COMTEX/—Amgen (Nasdaq: AMGN) will present at the Deutsche Bank 36th Annual Healthcare Conference on Tuesday, May 3, 2011 at the InterContinental, Boston, Mass., beginning at 9:20 a.m. Eastern Time. Senior Vice President of North America Commercial Operations Jim Daly will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen’s website, www.amgen.com, under Investors.

Read the rest of this entry

Posted in Press Releases

Thursday, April 21, 2011

Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans

Company Provides Guidance For 2015

Announces Quarterly Dividend Policy

NEW YORK, April 21, 2011 /PRNewswire via COMTEX/—Amgen (NASDAQ: AMGN) today outlined the Company’s strategy, capital allocation plans and provided financial guidance for 2015 during a meeting with investors in New York.

Read the rest of this entry

Posted in Press Releases

Thursday, April 21, 2011

Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)

Top-line Results Met Primary Endpoint

THOUSAND OAKS, Calif. and BRUSSELS, April 21, 2011 /PRNewswire via COMTEX/ —Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) announced today positive top-line results from their Phase 2 clinical study comparing sclerostin-antibody AMG 785/CDP7851 to placebo in postmenopausal women with low bone mineral density (BMD) for the treatment of postmenopausal osteoporosis (PMO).

Read the rest of this entry

Posted in Press Releases

Wednesday, April 20, 2011

Amgen's First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion

First Quarter 2011 Adjusted Earnings Per Share Increased 3 Percent To $1.34

First Quarter 2011 GAAP Earnings Per Share Increased 2 Percent To $1.20

THOUSAND OAKS, Calif., April 20, 2011 /PRNewswire via COMTEX/—Amgen (NASDAQ: AMGN) reported adjusted earnings per share (EPS) of $1.34 for the first quarter of 2011, an increase of 3 percent compared to $1.30 for the first quarter of 2010. Adjusted net income decreased 2 percent to $1,258 million in the first quarter of 2011 compared to $1,282 million in the first quarter of 2010.

Total revenue increased 3 percent during the first quarter of 2011 to $3,706 million versus $3,592 million in the first quarter of 2010.

Read the rest of this entry

Posted in Press Releases

Thursday, April 14, 2011

Amgen to Webcast 2011 Business Review Meeting on April 21

THOUSAND OAKS, Calif., April 14, 2011 /PRNewswire via COMTEX/—Amgen (Nasdaq: AMGN) today announced that it will hold its Business Review Meeting on Thursday, April 21, 2011 at the Mandarin Oriental Hotel, 80 Columbus Circle, New York City, beginning at 8 a.m. Eastern Time. In the meeting, Kevin Sharer, chairman and CEO, Robert A. Bradway, president and COO, Roger M. Perlmutter, M.D., Ph.D., executive vice president, Research and Development, and Jonathan M. Peacock, executive vice president and CFO, will discuss the Company’s strategy and long-term growth objectives, commercial performance and expectations, research and development innovation and pipeline progress, financial performance expectations and the Company’s capital allocation plan.

Read the rest of this entry

Posted in Press Releases